Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

Immunol Lett. 1995 Dec;48(2):149-52. doi: 10.1016/0165-2478(95)02448-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Growth Inhibitors / therapeutic use
  • Interleukin-12 / therapeutic use*
  • Lymphoma / immunology
  • Lymphoma / pathology
  • Lymphoma / therapy
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / pathology
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neoplasm Transplantation*
  • Papilloma / chemically induced
  • Papilloma / therapy
  • Stomach Neoplasms / chemically induced
  • Stomach Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Growth Inhibitors
  • Interleukin-12